Among the 398 samples which had mutation along with copy number alterations, in ovarian cancer, SLC16A3 has the highest percentage of alteration (4%) in the patient population and is followed by SLC16A1 comprising 2.5%; whereas SLC16A7 and SLC16A8 are the least altered genes at DNA level among all four functional members of the SLC16A family (Figure 2c). Here, SLC16A3 is linked to ovarian cancer.